Nextvel is supporting trials with (induced pluripotent stem cells (iPSCs), Antisense Oligonucleotide, CRISPR based Gene therapy product for Sickle Cell disease, and many more intellectually stimulating projects.

Nextvel is currently supporting IVD (in-vitro diagnostic) and medical devices registration with Indian, European (CE-Mark) and US that includes registrations of AI/ML based SaMD (software as medical device)